pcDNA 3.2-FUS-1-526aa-V5 Citations (3)
Originally described in: Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, Gitler AD PLoS Biol. 2011 Apr;9(4):e1000614. doi: 10.1371/journal.pbio.1000614. Epub 2011 Apr 26. PubMed Journal
Articles Citing pcDNA 3.2-FUS-1-526aa-V5
Articles |
---|
TDP-43 misexpression causes defects in dendritic growth. Herzog JJ, Deshpande M, Shapiro L, Rodal AA, Paradis S. Sci Rep. 2017 Nov 15;7(1):15656. doi: 10.1038/s41598-017-15914-4. PubMed |
Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis. Yan Y, Xu Z, Chen X, Wang X, Zeng S, Zhao Z, Qian L, Li Z, Wei J, Huo L, Li X, Gong Z, Sun L. Front Cell Dev Biol. 2019 Oct 2;7:217. doi: 10.3389/fcell.2019.00217. eCollection 2019. PubMed |
SAFB regulates hippocampal stem cell fate by targeting Drosha to destabilize Nfib mRNA. Forcella P, Ifflander N, Rolando C, Balta EA, Lampada A, Giachino C, Mukhtar T, Bock T, Taylor V. Elife. 2024 May 9;13:e74940. doi: 10.7554/eLife.74940. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.